PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-38.39%
Negative net income growth while ORCL stands at 55.28%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-14.38%
Negative yoy D&A while ORCL is 13.48%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-121.30%
Negative yoy deferred tax while ORCL stands at 404.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-478.19%
Negative yoy SBC while ORCL is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-194.74%
Both reduce yoy usage, with ORCL at -744.83%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-169.48%
AR is negative yoy while ORCL is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-204.19%
Both reduce yoy usage, with ORCL at -744.83%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
206.25%
Well above ORCL's 129.41%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-39.62%
Negative yoy CFO while ORCL is 53.93%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-77.87%
Both yoy lines negative, with ORCL at -76.62%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-1480.49%
Both yoy lines negative, with ORCL at -50.67%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
2.25%
Some yoy expansion while ORCL is negative at -65.29%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
24.84%
We have some liquidation growth while ORCL is negative at -54.96%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-191.19%
Both yoy lines negative, with ORCL at -100.00%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
110.37%
We have mild expansions while ORCL is negative at -1900.73%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-816.58%
Negative yoy issuance while ORCL is 103.39%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-4.93%
Both yoy lines negative, with ORCL at -0.70%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.